Full name
HIPRA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale of pharmaceutical goods
20.5 - Manufacture of other chemical products
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.75.Z - Wholesale of chemical products
47.73.Z - Dispensing chemist in specialised stores
64.20.Z - Activities of holding companies
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
72.19.Z - Other research and experimental development on natural sciences and engineering
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,4 | 1,7 | 2,7 | 56,2 |
EBITDA | 2,4 | 1,7 | 2,4 | 41,2 |
Short time liabilities | 4,4 | 5 | 4,6 | -9 |
Equity capital | 9,3 | 10,7 | 12,8 | 20,2 |
Operating profit (EBIT) | 2,3 | 1,6 | 2,3 | 39,8 |
Assets | 17,8 | 20 | 23,4 | 16,6 |
Net profit (loss) | 1,9 | 1,4 | 2,1 | 56,5 |
Cash | 5 | 3,8 | 12,2 | 225,1 |
Net income from sale | 55,1 | 57,6 | 62,2 | 8 |
Liabilities and provisions for liabilities | 8,5 | 9,4 | 10,6 | 12,6 |
Working assets | 17 | 19,2 | 22,2 | 15,7 |
Depreciation | 0 | 0,1 | 0,1 | 75,9 |
% | % | % | p.p. | |
Profitability of capital | 20,2 | 12,9 | 16,8 | 3,9 |
Equity capital to total assets | 52,2 | 53,2 | 54,8 | 1,6 |
Gross profit margin | 4,3 | 3 | 4,4 | 1,4 |
EBITDA Margin | 4,3 | 2,9 | 3,8 | 0,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 29 | 32 | 27 | -5 |
Current financial liquidity indicator | 2.0417938232421875 | 2.087047576904297 | 2.1448984146118164 | 0 |
Net dept to EBITDA | -2.1380083560943604 | -2.217435359954834 | -5.104592323303223 | -2,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane